Results for this period
First quarter1 June 2026 to 31 August 2026ConsolidatedJapanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
The Medical Care Sales Business benefited from higher sales of the 生漢煎 herbal medicine series, improved profitability from the price revision of SOKUYAKU system usage fees, and an increase in the number of companies adopting SOKUYAKU Benefit. The Healthcare Sales Business increased advertising investment to acquire new recurring customers. The Healthcare Marketing Business benefited from branding support, television shopping, direct mail and BPO services.
No applicable matters
| Item | Details |
|---|---|
| Fiscal Period Classification | First quarter |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 June 2026 to 31 August 2026 |
| Net Sales | ¥5,899 million (YoY +18.0%) |
| Operating profit | ¥83 million |
| Ordinary income | ¥68 million |
| Profit attributable to owners of the parent | ¥-10 million |
| Net income per share | ¥(1.92) |
| Equity ratio | End of the current fiscal period 12.5 / End of previous period 12.7 |
| Total assets | ¥9,594 million |
| Net assets | ¥1,498 million |
| Cash and cash equivalents at end of period | ¥2,030,710 thousand |
| Full-year earnings forecast | Net Sales ¥26,500 million (YoY +19.2%) / Operating profit ¥1,050 million (YoY +250.1%) / Ordinary income ¥1,000 million (YoY +148.3%) / Net income ¥550 million |
| Annual Dividend Forecast | ¥0.00 → ¥0.00（0.0%） |
| Segment revenue | Medical Care Sales business ¥1,507,998 thousand (YoY +17.9%), Healthcare Sales business ¥1,293,110 thousand (YoY -8.4%), Healthcare Marketing business ¥3,098,786 thousand (YoY +34.1%) |
| Segment profit | Medical Care Sales business ¥141,369 thousand, Healthcare Sales business ¥-104,403 thousand, Healthcare Marketing business ¥140,710 thousand |
| Depreciation and amortization | ¥9,018 thousand |
| Breakdown of extraordinary income (loss) | Extraordinary income Not disclosed / Extraordinary loss Loss on closure of stores ¥6,918 thousand |
| Disclosure regarding the going concern assumption | No applicable matters |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | New Number of companies 0 / Company name Not disclosed / Excluded Number of companies 0 / Company name Not disclosed |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | Whether applicable No / Subject person Not disclosed |
| Issued Shares at Period-End | 5,336,369 Shares |
| Treasury Shares at Period-End | 149 Shares |
| Factors Behind Changes in Business Performance | The Medical Care Sales Business benefited from higher sales of the 生漢煎 herbal medicine series, improved profitability from the price revision of SOKUYAKU system usage fees, and an increase in the number of companies adopting SOKUYAKU Benefit. The Healthcare Sales Business increased advertising investment to acquire new recurring customers. The Healthcare Marketing Business benefited from branding support, television shopping, direct mail and BPO services. |
Items this document does not state (11)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Higher sales of the 生漢煎 herbal medicine series, improved profitability from the price revision of SOKUYAKU system usage fees, an increase in the number of companies adopting SOKUYAKU Benefit, and branding support, television shopping, direct mail and BPO services in the Healthcare Marketing Business contributed to results. Meanwhile, EBITDA was negative in the Healthcare Sales Business because advertising investment was increased to acquire new recurring customers.